Dr. Joseph Labricciosa, DO

NPI: 1053315523
Total Payments
$23,129
2024 Payments
$3,264
Companies
72
Transactions
1,373
Medicare Patients
3,731
Medicare Billing
$462,161

Payment Breakdown by Category

Food & Beverage$22,809 (98.6%)
Education$320.60 (1.4%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $22,809 1,355 98.6%
Education $320.60 18 1.4%

Top Paying Companies

Company Total Records Latest Year
ABBVIE INC. $2,297 136 $0 (2024)
Novo Nordisk Inc $1,680 114 $0 (2024)
Lilly USA, LLC $1,543 86 $0 (2024)
Amgen Inc. $1,491 72 $0 (2024)
AstraZeneca Pharmaceuticals LP $1,317 76 $0 (2024)
Salix Pharmaceuticals, a division of Bausch Health US, LLC $1,158 125 $0 (2024)
GlaxoSmithKline, LLC. $1,064 66 $0 (2024)
Boehringer Ingelheim Pharmaceuticals, Inc. $1,037 46 $0 (2024)
Janssen Pharmaceuticals, Inc $891.01 61 $0 (2024)
Amarin Pharma Inc. $730.29 37 $0 (2022)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,264 173 ABBVIE INC. ($325.35)
2023 $3,081 198 ABBVIE INC. ($564.12)
2022 $2,702 159 ABBVIE INC. ($614.33)
2021 $2,656 181 AbbVie Inc. ($670.60)
2020 $2,584 163 Allergan, Inc. ($300.65)
2019 $3,315 195 Novo Nordisk Inc ($355.85)
2018 $3,172 164 Amgen Inc. ($430.77)
2017 $2,355 140 Amgen Inc. ($351.14)

All Payment Transactions

1,373 individual payment records from CMS Open Payments — Page 1 of 55

Date Company Product Nature Form Amount Type
12/23/2024 Otsuka America Pharmaceutical, Inc. NUEDEXTA (Drug) Food and Beverage In-kind items and services $16.02 General
Category: NEUROLOGY
12/20/2024 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $22.81 General
Category: RESPIRATORY
12/17/2024 Boehringer Ingelheim Pharmaceuticals, Inc. JARDIANCE (Drug) Food and Beverage In-kind items and services $24.38 General
Category: DIABETES
12/16/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $24.65 General
Category: PSYCHIATRY
12/13/2024 Tolmar, Inc. JATENZO (Drug) Food and Beverage Cash or cash equivalent $14.56 General
Category: HORMONE REPLACEMENT
12/05/2024 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $17.94 General
Category: Inflammation
12/04/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $15.03 General
Category: Gastroenterology
12/02/2024 SCPHARMACEUTICALS INC. FUROSCIX (Drug) Food and Beverage In-kind items and services $22.41 General
Category: Cardiology
11/26/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $19.95 General
Category: CNS Stimulant for ADHD
11/26/2024 Corium, LLC Azstarys (Drug) Food and Beverage In-kind items and services $2.51 General
Category: CNS Stimulant for ADHD
11/25/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $25.59 General
Category: PAIN
11/22/2024 AIMMUNE THERAPEUTICS, INC. ZENPEP (Drug) Food and Beverage In-kind items and services $21.89 General
Category: ENDOCRINE PANCREATIC INSUFFICIENCY
11/18/2024 PFIZER INC. NURTEC ODT (Drug), ZAVZPRET Food and Beverage In-kind items and services $18.33 General
Category: PAIN
11/18/2024 AstraZeneca Pharmaceuticals LP AIRSUPRA (Drug) Food and Beverage In-kind items and services $15.40 General
Category: Respiratory
11/16/2024 Almatica Pharma LLC LOREEV XR (Drug) Food and Beverage In-kind items and services $23.18 General
Category: ANTI-ANXIETY
11/15/2024 ABBVIE INC. VRAYLAR (Drug) Food and Beverage In-kind items and services $9.16 General
Category: NEUROSCIENCE
11/12/2024 Bayer Healthcare Pharmaceuticals Inc. Kerendia (Drug) Food and Beverage In-kind items and services $27.65 General
Category: Cardio-renal
11/11/2024 ABBVIE INC. Food and Beverage In-kind items and services $22.20 General
11/08/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $21.59 General
Category: UROLOGY
11/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $18.26 General
Category: Gastroenterology
11/06/2024 Salix Pharmaceuticals, a division of Bausch Health US, LLC XIFAXAN (Drug) Food and Beverage In-kind items and services $1.47 General
Category: Gastroenterology
11/05/2024 Axsome Therapeutics, Inc. Auvelity (Drug) Food and Beverage In-kind items and services $30.00 General
Category: Psychology/Psychiatric
11/04/2024 Otsuka America Pharmaceutical, Inc. REXULTI (Drug) Food and Beverage In-kind items and services $16.77 General
Category: PSYCHIATRY
11/01/2024 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) CAPLYTA (Drug) Food and Beverage In-kind items and services $24.94 General
Category: PSYCHIATRY
10/29/2024 Lilly USA, LLC MOUNJARO (Drug), ZEPBOUND Food and Beverage In-kind items and services $17.62 General
Category: Diabetes

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 12 1,018 1,543 $204,068 $117,332
2022 13 978 1,684 $216,057 $127,742
2021 13 913 1,528 $183,190 $112,907
2020 11 822 1,477 $203,185 $104,181
Total Patients
3,731
Total Services
6,232
Medicare Billing
$462,161
Procedure Codes
49

All Medicare Procedures & Services

49 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 338 774 $92,880 $47,135 50.7%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2023 246 246 $46,248 $32,787 70.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 113 153 $26,928 $14,608 54.2%
90662 Influenza vaccine split virus, preservative free Office 2023 90 90 $8,130 $6,377 78.4%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2023 22 22 $5,896 $3,769 63.9%
99349 Residence visit for established patient with moderate level of medical decision making, per day, if using time, at least 40 minutes Office 2023 11 38 $7,904 $3,243 41.0%
99496 Transitional care management services for problem of high complexity Office 2023 12 14 $5,236 $3,118 59.5%
G0008 Administration of influenza virus vaccine Office 2023 93 93 $3,720 $2,739 73.6%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 57 68 $5,032 $2,653 52.7%
G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and Office 2023 11 12 $1,044 $519.72 49.8%
96372 Injection of drug or substance under skin or into muscle Office 2023 11 18 $630.00 $211.32 33.5%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2023 14 15 $420.00 $172.15 41.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 324 943 $113,160 $60,010 53.0%
G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit Office 2022 242 242 $45,496 $33,412 73.4%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 94 124 $21,824 $12,317 56.4%
99349 Established patient home visit, typically 40 minutes Office 2022 14 55 $11,440 $5,351 46.8%
90662 Influenza vaccine split virus, preservative free Office 2022 70 70 $4,900 $4,798 97.9%
G0402 Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment Office 2022 20 20 $5,360 $3,528 65.8%
G0008 Administration of influenza virus vaccine Office 2022 94 94 $3,760 $2,659 70.7%
99495 Transitional care management services for problem of moderate complexity Office 2022 13 15 $3,975 $2,623 66.0%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2022 42 47 $3,478 $1,870 53.8%
90688 Influenza vaccine, quadrivalent, 0.5 ml dosage Office 2022 21 21 $630.00 $421.47 66.9%
98925 Osteopathic manipulative treatment, 1-2 body regions Office 2022 16 18 $900.00 $349.67 38.9%
96372 Injection of drug or substance under skin or into muscle Office 2022 16 22 $770.00 $243.58 31.6%
93000 Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report Office 2022 12 13 $364.00 $158.97 43.7%

About Dr. Joseph Labricciosa, DO

Dr. Joseph Labricciosa, DO is a Family Medicine healthcare provider based in Broomall, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/13/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053315523.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Labricciosa, DO has received a total of $23,129 in payments from pharmaceutical and medical device companies, with $3,264 received in 2024. These payments were reported across 1,373 transactions from 72 companies. The most common payment nature is "Food and Beverage" ($22,809).

As a Medicare-enrolled provider, Labricciosa has provided services to 3,731 Medicare beneficiaries, totaling 6,232 services with total Medicare billing of $462,161. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.

Practice Information

  • Specialty Family Medicine
  • Location Broomall, PA
  • Active Since 06/13/2005
  • Last Updated 02/21/2013
  • Taxonomy Code 207Q00000X
  • Entity Type Individual
  • Practice Solo Practitioner
  • NPI Number 1053315523

Products in Payments

  • VRAYLAR (Drug) $1,171
  • JARDIANCE (Drug) $1,120
  • XIFAXAN (Drug) $1,075
  • TRULICITY (Drug) $824.78
  • Ozempic (Drug) $768.66
  • Vascepa (Drug) $730.29
  • UBRELVY (Drug) $728.38
  • TRELEGY ELLIPTA (Drug) $702.79
  • FARXIGA (Drug) $628.42
  • XARELTO (Drug) $619.98
  • TROKENDI XR (Drug) $487.02
  • NURTEC ODT (Drug) $431.74
  • JANUVIA (Drug) $386.80
  • CAPLYTA (Drug) $385.52
  • LINZESS (Drug) $376.17
  • Aimovig (Biological) $374.79
  • Repatha (Biological) $356.57
  • Natesto (Drug) $352.86
  • REXULTI (Drug) $352.81
  • Prolia (Biological) $339.14

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Family Medicine Doctors in Broomall